Dr. brinker elected to Materials research society board of directors
Dr. Brinker has had an enduring and productive affiliation with MRS. In 1984 he co-organized one of four symposia at the first ever MRS Spring Meeting held in Albuquerque, NM, and in 1990 he was a co-organizer of the first MRS Spring Meeting to be held in the present location in San Francisco, CA. During this time period Brinker has co-organized over a dozen MRS symposia. In 1984 the interdisciplinary idea of ‘Better Ceramics Through Chemistry” (a spin-off of DuPont’s slogan at that time ‘better living through chemistry’) was a novel concept that has arguably evolved into our modern concept/notion of materials science.
Sandia captured five R & D 100 Awards in 2015. The awards include Chris Carlen's (8362) LED Pulser; Jason Hamlet (5627), Todd Bauer (1746), and Lyndon Pierson's (emeritus) Integrated Circuit Identification; Jim Brandt (9328), Ann Gentile (9328), and Benjamin Allan's (9328) Lightweight Distributed Metric Service; and Stan Atcitty's (611) JFET Switch. Susan Rempe and Jeff Brinker's CO2 Memzyme, won an R & D award, but also received the
R & D 100 contest's Green Technology Special Recognition Gold Award.
CO2 Memzyme is an ultra-thin membrane that is the first cost-effective technology for carbon dioxide separation and capture to meet and exceed the Department of Energy’s (DOE) targets for helping to reduce the threat of climate change.
Dr. Mitchell H. Gold, a nationally recognized pioneer in emerging cancer-fighting therapies, is throwing his weight behind a new, homegrown New Mexico technology that he believes could be a “game changer” in the battle against cancer.
The doctor, who helped usher in a new therapy for prostate cancer in 2010, is now working with researchers from the University of New Mexico and Sandia National Laboratories to commercialize a novel drug-delivery system that could make chemotherapy more effective while potentially eliminating toxic side effects.
The technology, known as the “protocell,” uses man-made nanoparticles to inject huge doses of cancer-killing drugs directly into the heart of tumors without harming healthy tissue.
Gold’s biotech investment firm, Alpine Biosciences, has acquired an option to license the protocell technology. It’s now setting up a local office to begin the commercialization process, and it’s planning a funding drive to raise up to $3 million in venture capital in the next six months.
“This is still early technology, but it’s so unique in its capabilities that I believe it will be a game changer for the entire field of oncology,” Gold told the Journal.
The National Academy of Inventors recognizes and encourages inventors who have a patent issued from the United States Patent and Trademark Office, enhances the visibility of university and non-profit research institute technology and academic innovation, encourages the disclosure of intellectual property, educates and mentors innovative students, and encourages the translation of the inventions of its members to benefit society.
Congratulations to Dr. Brinker for your achievements. Election to NAI Fellow status is a high professional distinction accorded to academic inventors who have demonstrated a highly prolific spirit of innovation in creating or facilitating outstanding inventions that have made a tangible impact on quality of life, economic development, and welfare of society.
Dr. Brinker is the recipient of a 2015 Innovation Award for U.S. Patents 8,663,742, "Durable Polymer/Aerogel Based Superhydrophobic Coatings, A Composite Material"; 8,734,816, "Porous Nanoparticle Supported Lipid Bilayer Nanostructures"; and 8,864,045, "Aerosol Fabrication Methods for Monodisperse Nanoparticles".
Congratulations to Dr. Brinker for your achievements as an outstanding UNM innovator whose technologies have generated significant commercialization activities.
Find more information about UNM STC Innovation Fellow Awards HERE.
Dr. Brinker just returned from the Fourth International Conference on Multifunctional Hybrid and Nanomaterials held in Sitges/Barcelona, Spain, March 9-13, 2015. Dr. Brinker served on the Conference Organizing Committee, and as a Session Chair and Featured Speaker.
The main objective of this large interdisciplinary conference is to bring together, at a truly international level, people with shared interests in hybrid materials, including; polymer chemists, physicists and engineers, biomaterials chemists, physicists and engineers, organic chemists, inorganic chemists, solid state chemists, sol-gel chemists, somposites scientists, colloid chemists and physicists, zeolite, meso- and microporous materials scientists, and broad nano- and materials scientists.
Find more information about Dr. Brinker's role in this conference HERE.